Pacira BioSciences (PCRX) Non-Current Deffered Revenue (2010 - 2022)

Pacira BioSciences' (PCRX) quarterly Non-Current Deffered Revenue came in at $10.1 million in Q1 2022, little changed quarter-over-quarter from $10.1 million in Q4 2021.

Pacira BioSciences (PCRX) Non-Current Deffered Revenue (2010 - 2022) Analysis & Trends

Pacira BioSciences' Non-Current Deffered Revenue history runs 10 years deep, the most recent figure standing at $10.1 million for Q1 2022.

  • On a quarterly basis, Non-Current Deffered Revenue changed N/A year-over-year to $10.1 million in Q1 2022; TTM through Mar 2022 was $10.1 million, a N/A change from a year earlier, with the FY2021 full-year figure at $10.1 million, changed N/A from the prior year.
  • Non-Current Deffered Revenue steadied at $10.1 million in Q1 2022 per PCRX's latest filing, from $10.1 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $10.1 million in Q4 2021 and bottomed at $10.1 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Pacira BioSciences 1.05 Bn 846.97 Mn 140.96 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2022 10.13 Mn
Dec 31, 2021 10.13 Mn
Mar 31, 2017 7.36 Mn
Dec 31, 2016 7.49 Mn
Sep 30, 2016 7.62 Mn
Jun 30, 2016 7.75 Mn
Mar 31, 2016 7.88 Mn
Dec 31, 2015 8.08 Mn
Sep 30, 2015 8.44 Mn
Jun 30, 2015 8.80 Mn
Mar 31, 2015 9.15 Mn
Dec 31, 2014 9.51 Mn
Sep 30, 2014 9.86 Mn
Jun 30, 2014 10.22 Mn
Mar 31, 2014 2.96 Mn
Dec 31, 2013 3.21 Mn
Sep 30, 2013 2.99 Mn
Jun 30, 2013 3.23 Mn
Mar 31, 2013 3.48 Mn
Dec 31, 2012 3.72 Mn